How do health care providers deal with kala-azar in the Indian subcontinent.

Simple item page
dc.contributor.authorKumar, Narendra
dc.contributor.authorSingh, Shri Prakash
dc.contributor.authorMondal, Dinesh
dc.contributor.authorJoshi, Anand
dc.contributor.authorDas, Pradeep
dc.contributor.authorSundar, Shyam
dc.contributor.authorKroeger, Axel
dc.contributor.authorHirve, Siddhivinayak
dc.contributor.authorSiddiqui, N A
dc.contributor.authorBoelaert, Marleen
dc.date.accessioned2011-12-08T10:36:31Z
dc.date.available2011-12-08T10:36:31Z
dc.date.issued2011-09
dc.description.abstractBackground & objectives: Three countries, Bangladesh, India and Nepal, set out to eliminate kala-azar by 2015. This study was aimed to document the knowledge and practices in kala-azar case management of public and private health providers in these three countries. Methods: A health care provider survey was conducted in 2007 at 4 study sites, viz., Muzaffarpur and Vaishali districts in India, Mahottari district in Nepal, and Rajshahi district in Bangladesh. Interviews were conducted with formal and informal health care providers at their home or practice. Results: About half of the providers in India and Nepal knew the rapid diagnostic test rK39 recommended by the elimination initiative, but this was not in Bangladesh. Knowledge of the recommended first-line drug, miltefosine, was good in India and Nepal but less so in Bangladesh. Interpretation & conclusions: Innovative tools for VL care have not yet been fully taken up by private for profit care providers in the three countries that launched a VL elimination initiative. The elimination initiative needs to address these gaps in private providers’ knowledge, given their substantial share in the care of VL patients.en_US
dc.identifier.citationKumar Narendra, Singh Shri Prakash, Mondal Dinesh, Joshi Anand, Das Pradeep, Sundar Shyam, Kroeger Axel, Hirve Siddhivinayak, Siddiqui N A, Boelaert Marleen. How do health care providers deal with kala-azar in the Indian subcontinent. Indian Journal of Medical Research. 2011 Sept; 134(3): 349-355.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/135767
dc.language.isoenen_US
dc.source.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193716/en_US
dc.subjectBangladeshen_US
dc.subjectcontrolen_US
dc.subjecteliminationen_US
dc.subjectIndiaen_US
dc.subjectNepalen_US
dc.subjectprovider surveyen_US
dc.subjectvisceral leishmaniasisen_US
dc.subject.meshBangladesh --epidemiology
dc.subject.meshCase Management
dc.subject.meshDisease Eradication --methods
dc.subject.meshDisease Eradication --statistics & numerical data
dc.subject.meshHealth Knowledge, Attitudes, Practice
dc.subject.meshHealth Personnel
dc.subject.meshHumans
dc.subject.meshIndia --epidemiology
dc.subject.meshInterviews as Topic
dc.subject.meshLeishmaniasis, Visceral --epidemiology
dc.subject.meshLeishmaniasis, Visceral --prevention & control
dc.subject.meshNepal --epidemiology
dc.subject.meshStatistics, Nonparametric
dc.titleHow do health care providers deal with kala-azar in the Indian subcontinent.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijmr2011v134n3p349.pdf
Size:
386.98 KB
Format:
Adobe Portable Document Format
Description:
Journal article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Indian Journal of Medical Research